Ken Griffin Nuvation Bio Inc. Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.58 - $3.69 $9,288 - $13,284
3,600 Added 124.14%
6,500 $18,000
Q1 2024

May 15, 2024
BUY
$1.46 - $3.97 $3,650 - $9,925
2,500 Added 625.0%
2,900 $10,000
Q4 2023

Feb 14, 2024
BUY
$0.96 - $1.53 $192 - $306
200 Added 100.0%
400 $0
Q3 2023

Nov 14, 2023
BUY
$1.26 - $2.1 $252 - $420
200 New
200 $0

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email